Cargando…
GOLM1 suppresses autophagy-mediated anti-tumor immunity in hepatocellular carcinoma
Autores principales: | Sui, Tianqi, Wang, Xiaoyang, Li, Lili, Liu, Junxiao, Qiao, Nan, Duan, Lihua, Shi, Minxin, Huang, Jianfei, Yang, Heng, Cheng, Genhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445956/ https://www.ncbi.nlm.nih.gov/pubmed/34531366 http://dx.doi.org/10.1038/s41392-021-00673-6 |
Ejemplares similares
-
Recent advances of GOLM1 in hepatocellular carcinoma
por: Yan, Jiuliang, et al.
Publicado: (2020) -
HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells
por: Li, Lili, et al.
Publicado: (2023) -
Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma
por: Lin, Yan, et al.
Publicado: (2022) -
The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy
por: Song, Qi, et al.
Publicado: (2021) -
GOLM1 exacerbates CD8(+) T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages
por: Chen, Jinhong, et al.
Publicado: (2021)